Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

UNIBIO A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   4.9% 3.5% 5.7% 8.2% 4.1% 5.5% 4.9% 4.7%   Credit score (0-100)   46 54 40 28 48 40 44 46   Credit rating   BBB BBB BBB BB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -7,445 -10,422 -13,099 -13,394 11,041 1,344 0.0 0.0   EBITDA   -22,275 -29,790 -40,811 -44,634 -58,489 -78,011 0.0 0.0   EBIT   -24,946 -32,667 -44,732 -48,392 -58,489 -78,011 0.0 0.0   Pre-tax profit (PTP)   -25,565.0 -33,316.0 -47,151.0 -47,533.0 -54,825.0 -76,548.0 0.0 0.0   Net earnings   -19,949.0 -25,984.0 -41,743.0 -41,849.0 -49,325.0 -78,336.0 0.0 0.0   Pre-tax profit without non-rec. items   -25,565 -33,316 -47,151 -47,533 -54,825 -76,548 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   21,476 20,840 24,913 24,478 23,436 26,542 0.0 0.0   Shareholders equity total   15,801 66,448 24,705 -17,144 33,531 155,195 144,445 144,445   Interest-bearing liabilities   14,383 25,786 22,960 117,497 22,663 4,980 0.0 0.0   Balance sheet total (assets)   44,436 105,536 67,667 118,875 71,343 174,899 144,445 144,445   Net Debt   10,372 -39,154 7,130 44,970 -3,532 -121,656 -143,273 -143,273     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -7,445 -10,422 -13,099 -13,394 11,041 1,344 0.0 0.0   Gross profit growth   -221.9% -40.0% -25.7% -2.3% 0.0% -87.8% -100.0% 0.0%   Employees   26 30 33 42 51 58 0 0   Employee growth %   36.8% 15.4% 10.0% 27.3% 21.4% 13.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   44,436 105,536 67,667 118,875 71,343 174,899 144,445 144,445   Balance sheet change%   29.5% 137.5% -35.9% 75.7% -40.0% 145.2% -17.4% 0.0%   Added value   -22,275.0 -29,790.0 -40,811.0 -44,634.0 -54,731.0 -78,011.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -746 -3,685 -1,953 -4,612 -1,242 2,906 -26,542 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   335.1% 313.4% 341.5% 361.3% -529.7% -5,804.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -63.3% -43.4% -51.6% -45.3% -52.6% -58.2% 0.0% 0.0%   ROI %   -94.5% -53.2% -63.8% -55.8% -62.8% -66.9% 0.0% 0.0%   ROE %   -126.4% -63.2% -91.6% -58.3% -64.7% -83.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   35.6% 63.0% 36.5% -12.6% 47.0% 88.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -46.6% 131.4% -17.5% -100.8% 6.0% 155.9% 0.0% 0.0%   Gearing %   91.0% 38.8% 92.9% -685.4% 67.6% 3.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.9% 3.9% 10.3% 2.0% 0.4% 30.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 2.5 1.1 0.7 1.2 7.4 0.0 0.0   Current Ratio   0.9 2.5 1.1 0.7 1.2 7.5 0.0 0.0   Cash and cash equivalent   4,011.0 64,940.0 15,830.0 72,527.0 26,195.0 126,636.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,180.0 48,392.0 5,236.0 -43,494.0 8,198.0 127,306.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -857 -993 -1,237 -1,063 -1,073 -1,345 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -857 -993 -1,237 -1,063 -1,147 -1,345 0 0   EBIT / employee   -959 -1,089 -1,356 -1,152 -1,147 -1,345 0 0   Net earnings / employee   -767 -866 -1,265 -996 -967 -1,351 0 0